Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
05/2010
05/04/2010US7709441 Using carbonic anhydrase related protein (CARP) as tool in treatment and prevention of calcium release disorders
05/04/2010US7709270 Using platelete derived growth factor as tool in detection of modulators for prevention and treatment of cell proliferative disorders
05/04/2010US7709255 Nerve cells obtained by the method of the present invention have the flexibility to differentiate into a variety of types of neurons in vivo preferably without the need for application of growth factors; Embryonic Stem (ES) cells
05/04/2010US7709217 Mixture comprising hemopoietic cytokine specific immunnoglobulin for use in detection of infection and immunololgical disorders
05/04/2010US7709028 Particulate product comprising pantethine
05/04/2010US7708984 Using immunoglobulin specific to adenoid expressed chemokine (ADEC) for prevention and treatment of cell proliferative, glandular and viral infection
05/04/2010CA2476587C Pharmaceutical formulation of iressa comprising a water-soluble cellulose derivative
05/04/2010CA2461013C Composition for lessening oxidative stress
05/04/2010CA2453609C Bridged piperidine derivatives as melanocortin receptor agonists
05/04/2010CA2440419C Azacycloalkyl substituted acetic acid derivatives for use as mmp inhibitors.
05/04/2010CA2437767C Heterocyclic inhibitors of erk2 and uses thereof
05/04/2010CA2427608C Condensed pyradizindione derivatives as pde inhibitors
05/04/2010CA2427385C Nutritional composition for an immune condition
05/04/2010CA2399196C Pyrimidine compounds
05/04/2010CA2367636C Fusion proteins
05/04/2010CA2347178C Methods of inhibiting smooth muscle cell proliferation and preventing restenosis with a vector expressing rb2/p130
05/04/2010CA2335364C Use of bi-specific antibodies for pre-targeting diagnosis and therapy
05/04/2010CA2320467C Cycloalkene derivatives, their production and use
05/04/2010CA2319057C Compositions comprising a poly(oxyethylene)-poly(oxypropylene) block copolymer and their use
05/04/2010CA2221568C Metabolic effects of certain glutathione analogs
04/2010
04/29/2010WO2010048564A1 Modulators of cystic fibrosis transmembrane conductance regulator
04/29/2010WO2010047756A1 Oral dosage forms including an antiplatelet agents and an enterically coated acid inhibitor
04/29/2010WO2010047372A1 2-aminopyridin-4-one and 2-aminopyridine derivative both having bace1-inhibiting activity
04/29/2010WO2010047361A1 Pharmaceutical composition improved in absorption through intestinal tract
04/29/2010WO2010047127A1 PHENANTHROINDOLIZIDINE COMPOUND AND NFκB INHIBITOR CONTAINING SAME AS ACTIVE INGREDIENT
04/29/2010WO2010047126A1 PHENANTHROINDOLIZIDINE DERIVATIVE AND NFκB INHIBITOR CONTAINING SAME AS ACTIVE INGREDIENT
04/29/2010WO2010047117A1 Novel monoclonal antibody and use thereof
04/29/2010WO2010045862A1 Drug for treating leucoderma
04/29/2010WO2010045787A1 The use of ginsenoside compound k in the manufacture of atherosclerosis medicine
04/29/2010US20100105953 Human Adam-10 Inhibitors
04/29/2010US20100105946 Hydrolytically Degradable Carbamate Derivatives of Poly(Ethylene Glycol)
04/29/2010US20100105922 Process for producing fused imidazole compound, reformatsky reagent in stable form, and process for producing the same
04/29/2010US20100105915 Chemokine receptor binding heterocyclic compounds
04/29/2010US20100105896 Pharmaceutical compounds
04/29/2010US20100105767 Compounds, compositions and methods
04/29/2010US20100105762 Therapeutic agent for periodontal disease and alveolar bone loss due to surgery
04/29/2010US20100105711 Organic Compounds
04/29/2010US20100105701 Gyrase inhibitors and uses thereof
04/29/2010US20100105683 Compounds useful for inhibiting chk1
04/29/2010US20100105682 Cyclopropyl-piperazine compounds as calcium channel blockers
04/29/2010US20100105649 Veterinary compositions for treating mastitis
04/29/2010US20100105648 Solid pharmaceutical composition comprising (r)-(-)-2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]chroman
04/29/2010US20100105633 Process
04/29/2010US20100105621 Therapies for acute renal failure
04/29/2010US20100105612 Agent containing fused protein of soluble rankl with epitope tag
04/29/2010US20100105603 Methods and Preparations For Curing Clinically Ill Patients
04/29/2010US20100105121 Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon
04/29/2010US20100104646 Nanoparticle composition for prevention of hair loss and promotion of hair growth
04/29/2010US20100104619 Delivery system for a non-steroidal non-ionized hydrophilic drug
04/29/2010US20100104608 Reactive surgical implant
04/29/2010US20100104588 Serum albumin binding peptides for tumor targeting
04/29/2010US20100104576 Polypeptide fusion comprising three nonoverlapping domains for use as tool in identifying modulator for enhancing immune response; immunization;
04/29/2010US20100104570 Semaphorin 7A Plays a Critical Role in TGF-Beta1-Induced Pulmonary Fibrosis and Alveolar Destruction
04/29/2010DE10085492B4 Antimonocytenaktivität von extrakten von Betelpfefferblättern Antimonocytenaktivität of extracts of Betelpfefferblättern
04/29/2010CA2742042A1 Modulators of cystic fibrosis transmembrane conductance regulator
04/29/2010CA2740810A1 Phenanthroindolizidine compound and nf.kappa.b inhibitor containing same as active ingredient
04/29/2010CA2740807A1 Phenanthroindolizidine derivative and nf.kappa.b inhibitor containing same as active ingredient
04/29/2010CA2739882A1 Pharmaceutical composition improving intestinal absorption
04/28/2010EP2180054A1 Methods and compositions for prolonging elimination half-times of bioactive compounds
04/28/2010EP2179997A1 Sulfonamide compound, and crystal thereof
04/28/2010EP2179994A1 Fused bicyclic compound
04/28/2010EP2179745A1 Combinations comprising epothilones and pharmaceutical uses thereof
04/28/2010EP2179738A2 Use of mesenchymal stem cells for treating osteoporosis
04/28/2010EP1487854B1 Novel isoform of vascular endothelial cell growth inhibitor (vegi)
04/28/2010EP1480650B1 Novel crystalline forms of the anti-cancer compound zd1839
04/28/2010EP1480615B1 Formoterol superfine formulation
04/28/2010EP1472225B1 2-piperazine-pyridines useful for treating pain
04/28/2010EP1461339B1 Spiroazacyclic compounds as monoamine receptor modulators
04/28/2010EP1420785B1 Substituted indeno [1,2-c]isoquinoline derivatives and methods of use thereof
04/28/2010EP1347751B1 Methods of treating bone cancer and the pain associated therewith using endothelin antagonists
04/28/2010EP1295607B1 Antitumor effect potentiators
04/28/2010CN1954818B Application of phillyrin in preparation for treating endotoxemia
04/28/2010CN1902352B Allergen suppressor, allergen-suppression processed fiber and method of producing the same
04/28/2010CN1863526B Collagen productin enhancer and production process and use thereof
04/28/2010CN1761686B Proteoglycan isolated from cartilaginous fish and process for producing the same
04/28/2010CN1758913B Use of pteridine derivatives for the treatment of increased intracranial pressure, secondary ischemia, and disorders associated with an increased level of cytotoxic reactive oxygen species
04/28/2010CN1747711B Melanogenesis inhibitor and skin preparation containing the same
04/28/2010CN1700917B Combination comprising N-{5-[4-(4-methyl-piperazino-methyl)-benzoylamido]-2-methylphenyl}-4-(3-pyridyl)-2pyrimidine-amine and a chemotherapeutic agent
04/28/2010CN1662260B Process for producing sustained-release composition
04/28/2010CN1658877B Basic non-peptide bradykinin antagonists and pharmaceutical compositions therefrom
04/28/2010CN1658855B O-substituted hydroxyaryl derivatives
04/28/2010CN1652698B Method and dietary composition for improving lipid digestibility
04/28/2010CN1652697B Method and dietary composition for improving fat digestibility
04/28/2010CN1652696B Method of improving absorption of vitamin E by a pet animal
04/28/2010CN1620257B Matrix-forming composition containing pectin
04/28/2010CN1615743B Compound soybean isoflavone health tablet
04/28/2010CN1593473B Application of a pharmaceutical composition in the preparing process of medicine for treating chronic alcohol intake caused injury
04/28/2010CN1556808B Cosmetic comprising heterocyclic compound based on N6-substituted adenine,
04/28/2010CN1556705B 7,8,9,10-tetrahydro-6H-azepino, 6,7,8,9-tetrahydro-pyrido and 2,3-dihydro-2H-pyrrolo[2,1-b]-quinazolinone derivatives
04/28/2010CN1468307B Anti-dual integrin antibodies, compositions, methods and uses
04/28/2010CN101698102A Ultra-potent composite for decontaminating hazardous chemical substances
04/28/2010CN101698088A Traditional Chinese medicine for treating hyperblastosis of human body
04/28/2010CN101698025A Growth-promoting height increasing agent for children
04/28/2010CN101698024A Traditional Chinese medicine for treating respiratory diseases and promoting growth for swine and preparation method thereof
04/27/2010USRE41279 made by combining aqueous composition containing visual indicator and organic components and aqueous solution of salt of chlorous acid, preferably alkali metal chlorite; materials are blended into viscous material containing emollient package which generates active antimicrobial chlorine dioxide
04/27/2010USRE41278 useful to alleviate or improve various cosmetic conditions and dermatological disorders, including changes or damage to skin, nail and hair associated with intrinsic aging and/or extrinsic aging, as well as changes or damage caused by extrinsic factors
04/27/2010US7705044 Benzamidoacetonitriles and their use as antiparasitics
04/27/2010US7705039 Method for treating sleep apnea
04/27/2010US7705015 Substituted pyrroline kinase inhibitors
04/27/2010US7704999 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors
1 ... 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 ... 1564